Health-related Quality of Life and Virologic Outcomes in an HIV Clinic

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2001 May 3

PMID 11332226

Citations 48

Authors

S A Call

J C Klapow

K E Stewart

A O Westfall

A P Mallinger

R A DeMasi

R Centor

M S Saag

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this study was to describe the relationship between viral load and health-related quality of life (HRQOL) in a cohort of persons with human immunodeficiency virus (HIV) infection.

Design: We evaluated HRQOL measurements in a clinical cohort of HIV-positive patients recruited from a university-associated HIV primary care clinic. HRQOL instruments included the medical outcomes survey-short form-36(MOS-SF-36) from which mental and physical component summary scores (MCS and PCS) and subscale scores were calculated.

Results: Significant negative associations were found between viral load and SF-36 PCS, physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), role-emotional (RE), and vitality (VT). Similar negative associations were found between CD4 cell count and SF-36 summary and subscale scores, with the notable exception of bodily pain. Multivariate analyses controlling for the effects of CD4 cell count and other clinical variables indicated viral load as an independent predictor of SF-36 PCS, RP, BP and VT scores.

Conclusions: The relationship between viral load, a measure of HIV disease activity, and several dimensions of the SF-36, a patient-focused measure of HRQOL, appears to be strong and independent of CD4 cell count. These findings suggest that having a lower viral load positively impacts the quality of life of HIV-positive patients.

Citing Articles

Portilla-Tamarit I, Rubio-Aparicio M, Fuster-RuizdeApodaca M, Portilla-Tamarit J, Reus S, Portilla J AIDS Behav. 2024; 28(6):1978-1998.

PMID: 38743382 PMC: 11161547. DOI: 10.1007/s10461-024-04298-y.

Empirical Development of a Behavioral Intervention for African American/Black and Latino Persons with Unsuppressed HIV Viral Load Levels: An Application of the Multiphase Optimization Strategy (MOST) Using Cost-Effectiveness as an Optimization....

Feelemyer J, Braithwaite R, Zhou Q, Cleland C, Manandhar-Sasaki P, Wilton L AIDS Behav. 2024; 28(7):2378-2390.

PMID: 38662280 PMC: 11415978. DOI: 10.1007/s10461-024-04335-w.

Factors associated with poorer quality of life in people living with HIV in southwestern France in 2018-2020 (ANRS CO3 AQUIVIH-NA cohort: QuAliV study).

Barger D, Hessamfar M, Neau D, Farbos S, Leleux O, Cazanave C Sci Rep. 2023; 13(1):16535.

PMID: 37783722 PMC: 10545822. DOI: 10.1038/s41598-023-43434-x.

Alford K, Banerjee S, Daley S, Hamlyn E, Trotman D, Vera J J Int Assoc Provid AIDS Care. 2023; 22:23259582231164241.

PMID: 36945871 PMC: 10034276. DOI: 10.1177/23259582231164241.

Transportation Barriers and Health-Related Quality of Life in a Sample of Middle-Aged and Older Adults Living with HIV in the Deep South.

Pope C, Stavrinos D, Fazeli P, Vance D AIDS Behav. 2022; 26(7):2148-2158.

PMID: 35066731 PMC: 8783768. DOI: 10.1007/s10461-021-03560-x.

References

Wu A, Hays R, Kelly S, Malitz F, Bozzette S . Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997; 6(6):531-54. DOI: 10.1023/a:1018460132567. View

Tsevat J, Solzan J, Kuntz K, Ragland J, Currier J, Sell R . Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. Med Care. 1996; 34(1):44-57. DOI: 10.1097/00005650-199601000-00004. View

Hughes T, Kaplan R, Coons S, Draugalis J, Johnson J, Patterson T . Construct validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients. Med Decis Making. 1997; 17(4):439-46. DOI: 10.1177/0272989X9701700409. View

Ragsdale D, Morrow J . Quality of life as a function of HIV classification. Nurs Res. 1990; 39(6):355-9. View

Bozzette S, Hays R, Berry S, Kanouse D, Wu A . Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8(3):253-65. DOI: 10.1097/00042560-199503010-00006. View

OKeefe E, Wood R . The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population. Qual Life Res. 1996; 5(2):275-80. DOI: 10.1007/BF00434749. View

Williams J, Rabkin J . The concurrent validity of items in the Quality-of-Life Index in a cohort of HIV-positive and HIV-negative gay men. Control Clin Trials. 1991; 12(4 Suppl):129S-141S. DOI: 10.1016/s0197-2456(05)80018-2. View

Hammer S, Squires K, Hughes M, Grimes J, Demeter L, Currier J . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med. 1997; 337(11):725-33. DOI: 10.1056/NEJM199709113371101. View

Coombs R, Welles S, Hooper C, Reichelderfer P, DAquila R, Japour A . Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA.... J Infect Dis. 1996; 174(4):704-12. DOI: 10.1093/infdis/174.4.704. View

10.

Ryan C, White J . Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction. 1996; 91(1):39-45. DOI: 10.1046/j.1360-0443.1996.911397.x. View

11.

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

12.

Revicki D, Wu A, Murray M . Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Med Care. 1995; 33(4 Suppl):AS173-82. View

13.

Gulick R . Current antiretroviral therapy: an overview. Qual Life Res. 1997; 6(6):471-4. DOI: 10.1023/a:1018447829842. View

14.

Holmes W, Bix B, Shea J . SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. Med Care. 1996; 34(6):562-9. DOI: 10.1097/00005650-199606000-00006. View

15.

Hays R, Shapiro M . An overview of generic health-related quality of life measures for HIV research. Qual Life Res. 1992; 1(2):91-7. DOI: 10.1007/BF00439716. View

16.

Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C . Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med. 1992; 116(2):129-37. DOI: 10.7326/0003-4819-116-2-129. View

17.

Anderson J, Kaplan R, Coons S, Schneiderman L . Comparison of the Quality of Well-being Scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. J Clin Epidemiol. 1998; 51(9):755-62. DOI: 10.1016/s0895-4356(98)00046-8. View

18.

Smith M, Feldman J, Kelly P, DeHovitz J, Chirgwin K, Minkoff H . Health-related quality of life of HIV-infected women: evidence for the reliability, validity and responsiveness of the Medical Outcomes Study Short-Form 20. Qual Life Res. 1996; 5(1):47-55. DOI: 10.1007/BF00435968. View